In OGTT and ITT tests, db-CB0313.1 mice exhibited improved glucose tolerance at individual time points compared with db-diabetic mice with respect to area under the blood glucose response curve (AUC) (Fig
We desperately need to see more tracking and monitoring of how much they are taking, side effects and ultimate weight loss / inflammation decrease etc
Retatrutide's glucagon arm produces more nausea than pure GLP-1 compounds, so stabilizing it first makes it much easier to tell where any new symptom is coming from
Both require a consultation, a clinical evaluation, and a protocol built around the patients actual goals and body composition data
To be profitable then, a D2C platform would need patients to pay a premium for one of two things where they can make margin
Regenerative medicine Addresses the upstream biology the cellular environment in which degeneration occurs